Board of Directors
The Novartis Board of Directors is responsible for the direction, strategy, organization and administration of the company. The Board comprises 14 members with Joerg Reinhardt as chairman.
Download the Board of Director Committee Organizational Chart (PDF 0.1 MB)
Joerg Reinhardt, Ph.D.

Enrico Vanni, Ph.D.

Nancy C. Andrews, M.D., Ph.D.

Nancy C. Andrews, M.D., Ph.D.
Ton Buechner

Ton Buechner
Patrice Bula

Patrice Bula
Srikant Datar, Ph.D.

Srikant Datar, Ph.D.
Elizabeth (Liz) Doherty

Elizabeth (Liz) Doherty
Ann Fudge

Ann Fudge
Bridgette Heller

Bridgette Heller
Frans van Houten

Frans van Houten
Simon Moroney

Simon Moroney, D.Phil.
Andreas von Planta, Ph.D.

Andreas von Planta, Ph.D.
Charles L. Sawyers, M.D.

Charles L. Sawyers, M.D.
William T. Winters

William T. Winters
Charlotte Pamer-Wieser, Ph.D.

Corporate Governance
Novartis is fully committed to good corporate governance.